Santa Cruz Biotechnology features a diverse variety of probasin Antibodies for research focused on understanding probasin's role in various biological processes. probasin Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Probasin is primarily expressed in the prostate and plays a critical role in regulating prostate-specific gene expression. Research has shown probasin's involvement in prostate cancer progression, making it an important marker for studying prostate-related diseases. Understanding probasin function provides valuable insights into molecular mechanisms underlying prostate cancer. Ongoing research continues to reveal new aspects of probasin's biological significance and potential therapeutic implications. Advanced research tools enable scientists to investigate probasin's role in normal prostate development and disease states. Exploring probasin's regulatory mechanisms helps identify potential therapeutic targets for prostate cancer treatment. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of prostate biology and disease mechanisms.